IRCCS Istituto Nazionale dei Tumori
Milan, Lombardy
0 studies enrolling now · 1 studies all time
What they study most
Renal Cell Carcinoma
Studies at this site
Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma
— Completed